DUXAP9 and non-small cell lung carcinoma: In situ hybridization (ISH) analysis using a specific probe revealed that the expression levels of DUXAP9‐206 were significantly elevated in NSCLC tumour tissues compared with paired adjacent non‐tumour tissues (Figure 1A).